1. Home
  2. NBTX vs VOR Comparison

NBTX vs VOR Comparison

Compare NBTX & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NBTX
  • VOR
  • Stock Information
  • Founded
  • NBTX 2003
  • VOR 2015
  • Country
  • NBTX France
  • VOR United States
  • Employees
  • NBTX N/A
  • VOR N/A
  • Industry
  • NBTX Biotechnology: Pharmaceutical Preparations
  • VOR Biotechnology: Pharmaceutical Preparations
  • Sector
  • NBTX Health Care
  • VOR Health Care
  • Exchange
  • NBTX Nasdaq
  • VOR Nasdaq
  • Market Cap
  • NBTX 211.9M
  • VOR 202.4M
  • IPO Year
  • NBTX 2020
  • VOR 2021
  • Fundamental
  • Price
  • NBTX $6.93
  • VOR $2.29
  • Analyst Decision
  • NBTX Strong Buy
  • VOR Buy
  • Analyst Count
  • NBTX 1
  • VOR 7
  • Target Price
  • NBTX $8.00
  • VOR $3.77
  • AVG Volume (30 Days)
  • NBTX 6.8K
  • VOR 13.5M
  • Earning Date
  • NBTX 09-17-2025
  • VOR 08-11-2025
  • Dividend Yield
  • NBTX N/A
  • VOR N/A
  • EPS Growth
  • NBTX N/A
  • VOR N/A
  • EPS
  • NBTX N/A
  • VOR N/A
  • Revenue
  • NBTX N/A
  • VOR N/A
  • Revenue This Year
  • NBTX N/A
  • VOR N/A
  • Revenue Next Year
  • NBTX $221.06
  • VOR N/A
  • P/E Ratio
  • NBTX N/A
  • VOR N/A
  • Revenue Growth
  • NBTX N/A
  • VOR N/A
  • 52 Week Low
  • NBTX $2.76
  • VOR $0.13
  • 52 Week High
  • NBTX $7.29
  • VOR $3.29
  • Technical
  • Relative Strength Index (RSI)
  • NBTX 71.78
  • VOR 61.50
  • Support Level
  • NBTX $6.49
  • VOR $2.15
  • Resistance Level
  • NBTX $7.15
  • VOR $2.65
  • Average True Range (ATR)
  • NBTX 0.34
  • VOR 0.28
  • MACD
  • NBTX 0.14
  • VOR -0.06
  • Stochastic Oscillator
  • NBTX 84.58
  • VOR 50.00

About NBTX Nanobiotix S.A.

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

About VOR Vor Biopharma Inc.

Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.

Share on Social Networks: